Navigation Links
Repligen Reports Second Quarter Fiscal Year 2009 Financial Results
Date:11/6/2008

signation by the FDA, a process designed to facilitate the development and expedite the review of drugs that treat serious diseases and fill an unmet medical need. There are more than 300,000 procedures conducted in the United States and Europe each year that may benefit from enhancement with RG1068.

RG2417 for Bipolar Disorder

We have initiated a Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial in which approximately 150 patients with bipolar depression will receive either RG2417 or a placebo twice a day for eight weeks. This study is designed to assess the efficacy and safety of RG2417 on the symptoms of depression as measured by the Montgomery-Asberg Depression Rating Scale (MADRS) and the Clinical Global Impression of Change in Bipolar Disorder scale (CGI-BP-C). This study is based on the positive results of a Phase 2a study in which 83 patients received either RG2417 or a placebo twice a day for six weeks. Over the six- week treatment period, the study demonstrated a statistically significant improvement in the symptoms of depression in the patients receiving RG2417 when compared to placebo on the MADRS (p=0.01) and the CGI-BP-C (p=0.04).

HDAC Inhibitors for Friedreich's Ataxia and Huntington's Disease

We are currently developing inhibitors of histone deacetylases (HDACs) which may have utility in treating progressive, inherited neurodegenerative diseases such as Friedreich's ataxia and Huntington's disease. We have identified several potential clinical candidates and are further characterizing these leads in animal models for their pharmacologic, toxicologic and pharmacodynamic profiles. Repligen announced receipt of a $1 million research grant from the Muscular Dystrophy Association and a $125,000 grant from the Friedreich's Ataxia Research Alliance and the National Ataxia Foundation. The grants
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
2. Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST
3. Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
4. Repligen Announces Share Repurchase Program
5. Repligen Announces Conference Call to Update Orencia(R) Lawsuit
6. Repligen Elects Earl Henry, M.D. to the Board of Directors
7. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
8. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
9. Stereotaxis Reports Third Quarter 2008 Financial Results
10. Volcano Reports 40 Percent Growth in Quarterly Revenues
11. Dialysis Corporation of America Reports Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... Wisconsin (PRWEB) September 20, 2014 QueenBeeTickets.com ... the young star’s tour performances. She will visit many ... of February until the 16th of April. , ... Grande Honeymoon Tour tickets at QueenBeeTickets.com. , The star’s ... opportunity to see their favorite young singer in a ...
(Date:9/20/2014)... AZ (PRWEB) September 20, 2014 The ... Community College (MCC) is celebrating National Manufacturing Day by ... its enhanced machining, processing and additive manufacturing labs will ... Oct. 3, 2014 at MCC’s Southern and Dobson campus ... available in southeast Lot D. , The AzAMI at ...
(Date:9/20/2014)... 2014 MarijuanaDoctors.com recently returned to ... the PAIN Week conference that was held at ... in Las Vegas from September 2nd to September ... Week in the hopes of educating physicians in ... legitimate tool to treat chronic Pain, MarijuanaDoctors.com accomplished ...
(Date:9/19/2014)... 2014 Consistent premium price increases ... Vision Insurance industry in recent years; however, costs ... industry margins. From 2009 to 2014, industry revenue ... coverage for routine eye exams and other procedures, ... lens and refractive surgery. According to IBISWorld Industry ...
(Date:9/19/2014)... City, KS (PRWEB) September 19, 2014 ... is responding to families in regions of the Philippines being ... , More than 1,060 families evacuated to the nearest ... storm Fung-Wong brought heavy rain and gusty winds to portions ... Friday causing heavy flooding. Some homes filled with more than ...
Breaking Medicine News(10 mins):Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:National Manufacturing Day Open House at Mesa Community College Oct. 3 2Health News:MarijuanaDoctors.com Experiences Unprecedented Support and Growth at Pain Week 2014 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2
... risk, study finds , WEDNESDAY, Feb. 3 (HealthDay News) ... associated with increased loss of bone mineral density and ... premature death, researchers say. , "Our findings highlight the ... fracture risk," Dr. Sophie A. Jamal, of the University ...
... , CINCINNATI , Feb. 3 ... as the winningest in franchise history, with a first time trip to ... BREES ( PURDUE ) consistent and dependable blocking throughout the ... Orleans Saints offensive line was the first to be honored and named ...
... , SAN DIEGO , Feb. 3 ... named among the top 100 integrated health care networks in the nation ... analyst. Sharp was ranked No. 6 in the nation and No. 1 ... by Modern Healthcare , is regarded as the nation,s premier rating ...
... , , New York ,s Automobile Insurance System Is Currently ... Feb. 3 Fraud and abuse in New York ... million in 2009, constituting a "fraud tax" of $1,561 , ... Hartwig , an economist and president of the Insurance Information Institute ...
... linking obesity and DNA , WEDNESDAY, Feb. 3 (HealthDay News) ... European scientists report that a genetic variation seems to virtually ... variation in question robs people of about 30 genes and ... obese people, the researchers report. The same variation also may ...
... ... New Jersey , ... 3, 2010 -- IntertechPira is pleased to announce the dates and location for the 8th ... Newark, New Jersey on October 18 - 20, this event promises to provide attendees with ...
Cached Medicine News:Health News:Kidney Function May Be Tied to Bone Loss 2Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 2Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 3Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 4Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 5Health News:Sharp HealthCare Rated Top Health Care Network in California and No. 6 in the Nation 2Health News:Inflated Medical Bills and Bogus Claims Drive Up Cost of No-Fault Auto Insurance in New York, I.I.I. Finds 2Health News:Inflated Medical Bills and Bogus Claims Drive Up Cost of No-Fault Auto Insurance in New York, I.I.I. Finds 3Health News:Inflated Medical Bills and Bogus Claims Drive Up Cost of No-Fault Auto Insurance in New York, I.I.I. Finds 4Health News:Very Obese People May Be Missing Genes 2Health News:Dates Announced for IntertechPira's 8th Color Cosmetics Summit 2
(Date:9/19/2014)... , Sept. 19, 2014 /PRNewswire-iReach/ -- ... Oxybutynin Hydrochloride Industry, 2009-2019 is a professional ... Chinese Oxybutynin Hydrochloride industry. The report firstly ... including its classification, application and manufacturing technology. ... top manufacturers of Oxybutynin Hydrochloride listing their ...
(Date:9/19/2014)... Sept. 19, 2014 /PRNewswire-iReach/ -- "United ... 2020″, provides key market data on ... market. The report provides value, in ... (in units) within market categories – ... Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, ...
(Date:9/19/2014)... -- Kiromic, LLC, a Lubbock bio-pharmaceutical ... the former chancellor of Texas Tech University, to its board ... 2014, after raising $1.2 billion for the university. ... the most successful chancellor in the history of Texas Tech ... investor, but also as our new vice chairman of the ...
Breaking Medicine Technology:Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2
... Pharmaceuticals (Nasdaq: ENDP ) announced today that it has ... related to LecTec,s U.S. Patent Nos. 5,536,263 and 5,741,510. , ... payment for the exclusive license to these two patents for ... "We are pleased to add these patents to our IP ...
... CLEVELAND, Nov. 11 ChanTest, a leading provider of ... for drug discovery and development, today announced that Dr. ... to its board of directors. Dr. Mills is presently ... logistics, and biological specimens and data storage services for ...
Cached Medicine Technology:Endo Pharmaceuticals and LecTec Settle Patent Dispute 2Endo Pharmaceuticals and LecTec Settle Patent Dispute 3Endo Pharmaceuticals and LecTec Settle Patent Dispute 4Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation 2
... navigation system for ENT, cranial and ... zones preoperatively, critical zones visible during ... direct vision, one button freezes image, ... image. Microscope interface: tracks focal point ...
... The spinal system neon is a modular ... extends from occipitocervical via cervical to cervicothoracic ... can be used for the entire spinal ... connection used by the system also provides ...
...
...
Medicine Products: